These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15787602)

  • 1. Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy.
    Bridges AJ
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):343-5. PubMed ID: 15787602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications.
    Bullock WH; Magnuson SR; Choi S; Gunn DE; Rudolph J
    Curr Top Med Chem; 2002 Sep; 2(9):915-38. PubMed ID: 12171564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pp120, a substrate of the insulin receptor tyrosine kinase, is associated with phosphatase activity.
    Najjar SM
    Biochem Biophys Res Commun; 1998 Jun; 247(2):457-61. PubMed ID: 9642150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK.
    Zierath JR
    IDrugs; 2005 Feb; 8(2):121-3. PubMed ID: 15696413
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid phosphatases as drug discovery targets for type 2 diabetes.
    Lazar DF; Saltiel AR
    Nat Rev Drug Discov; 2006 Apr; 5(4):333-42. PubMed ID: 16582877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinases in diabetes. Part I. 11-12 November 2004, Manchester, UK.
    Zierath JR
    IDrugs; 2005 Feb; 8(2):118-20. PubMed ID: 15696412
    [No Abstract]   [Full Text] [Related]  

  • 11. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
    Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
    Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges for the development of covalent chemical immunomodulators.
    Backus KM; Cao J; Maddox SM
    Bioorg Med Chem; 2019 Aug; 27(15):3421-3439. PubMed ID: 31204229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].
    Liu SN; Shen ZF
    Yao Xue Xue Bao; 2007 Dec; 42(12):1227-31. PubMed ID: 18338632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
    Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does inhibition of tyrosine phosphatase 1B protect from obesity and type 2 diabetes?].
    Ukkola O; Santaniemi M
    Duodecim; 2002; 118(18):1857-62. PubMed ID: 12422667
    [No Abstract]   [Full Text] [Related]  

  • 17. A Multiplexed NMR-Reporter Approach to Measure Cellular Kinase and Phosphatase Activities in Real-Time.
    Thongwichian R; Kosten J; Benary U; Rose HM; Stuiver M; Theillet FX; Dose A; Koch B; Yokoyama H; Schwarzer D; Wolf J; Selenko P
    J Am Chem Soc; 2015 May; 137(20):6468-71. PubMed ID: 25963544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of kinases, phosphatases, and phosphorylation sites in human and porcine spermatozoa.
    Lackey BR; Gray SL
    Syst Biol Reprod Med; 2015; 61(6):345-52. PubMed ID: 26467841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits inositide trisphosphate accumulation in hypothalamus and regulates food intake and body weight.
    Bertelli DF; Araújo EP; Cesquini M; Stoppa GR; Gasparotto-Contessotto M; Toyama MH; Felix JV; Carvalheira JB; Michelini LC; Chiavegatto S; Boschero AC; Saad MJ; Lopes-Cendes I; Velloso LA
    Endocrinology; 2006 Nov; 147(11):5385-99. PubMed ID: 16916951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.